1 Min Read
May 24 (Reuters) - Sun Pharmaceutical Industries Ltd :
* Sun Pharma announces U.S. FDA filing acceptance of Biologics License Application (bla) for tildrakizumab Source text for Eikon: Further company coverage:
All quotes delayed a minimum of 15 minutes. See here for a complete list of exchanges and delays.
© 2017 Reuters. All Rights Reserved.